Related Experiment Videos
Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4
P Reusch1, S Arnold, C Heusser
1Theodor-Boveri-Institut für Biowissenschaften (Biozentrum) der Universität, Würzburg, Germany.
European Journal of Biochemistry
|June 1, 1994
Summary
Monoclonal antibodies targeting human interleukin-4 (IL-4) identified key functional epitopes. Blocking antibodies on helix D inhibited IL-4 function without affecting receptor binding, revealing distinct mechanisms.
Area of Science:
- Immunology
- Protein Structure-Function Analysis
Background:
- Human interleukin-4 (IL-4) is crucial for immune responses against parasites and implicated in allergic diseases.
- Understanding IL-4's interaction with its receptor is vital for therapeutic development.
Purpose of the Study:
- To identify functionally important epitopes on human IL-4.
- To map specific amino acid residues involved in IL-4's interaction with its receptor and its biological function.
Main Methods:
- Utilized seven neutralizing monoclonal antibodies (mAbs) against human IL-4.
- Analyzed 41 IL-4 variants with specific amino acid substitutions to assess mAb binding affinity.
- Correlated amino acid changes with effects on IL-4 receptor binding and function.
Main Results:
- Identified four distinct epitopes on human IL-4 based on mAb binding.
- mAbs targeting epitopes on helix A and/or C inhibited IL-4 receptor binding and function.
- mAbs targeting helix D inhibited IL-4 function but not receptor binding, indicating a distinct signaling site.
- One mAb targeting N-terminal and C-terminal residues partially competed for receptor binding.
Conclusions:
- Amino acid residues in helices A and C are critical for IL-4 binding to its receptor.
- Helix D contains a signaling site that interacts with a separate receptor component, crucial for IL-4 function.
- Distinct epitopes on IL-4 mediate receptor binding versus functional signaling, offering potential for targeted therapies.